Investigation of in vitro and invivo performance of injectable in situ implants;Enjekte Edilebilen In situ implantların In vitro ve In vivo Performanslannin Araştinlması

Turkish Journal of Pharmaceutical Sciences

Volumn 7, Issue 1, 2010, Pages 9-20

  Yapar, Evren Alǧin ^a   Ari, Nuray ^a   Baykara, Tamer ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Granisetron HCl; In situ implant; Injectable; Poly(DL lactide co glycolide); Rabbit

Indexed keywords

BENZYL BENZOATE; GRANISETRON; PROPYLENE CARBONATE; RESOMER;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG IMPLANT; DRUG RELEASE; DRUG SOLUBILITY; DRUG STERILITY; DRUG TRANSPORT; GAMMA IRRADIATION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; RABBIT; STEADY STATE;

EID: 77955440614     PISSN: 1304530X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Dunn, R.L., English, J.P., Cowsar, D.R., Vanderbilt, D.P., "Biodegradable in-situ forming implants and methods of producing", US Patent, 5990194, 1999.
2. Eliaz, R.E., Kost, J., "Characterization of a polymeric PLGA-injectable implant delivery system for controlled release of proteins", J. Biomed. Mater. Res., 50, 388-396, 2000.
3. Algin, E., Baykara, T., "In situ forming injectable implant systems", J. Fac Pharm. Ankara., 34(4), 287-313, 2005.
4. Astaneh, R., Moghimi, H.R., Erfan, M., Mobedi, H., "Formulation of an injectable implant for peptide delivery and mechanistic study of the effect of polymer molecular weight on its release behaviour", Daru, 14(2), 65-70, 2006.
5. Kempe, S., Metz, H., Mäder, K., "Do in situ forming PLG/NMP implants behave similar in vitro and in vivo? A non-invasive and quantitative EPR investigation on the mechanisms of the implant formation process", J. Control. Release, 130(3), 220-225, 2008.
6. Algin Yapar, E., Baykara, T., "Evaluation of solvent effects on drug release from injectable phase sensitive liquid implant systems", J. Fac. Pharm. Ankar., 37(2), 101-109, 2008.
7. Bakhshi, R., Vasheghani-Farahani, E., Mobedi, H., Jamshidi, A., Khakpour, M., "The effect of additives on naltrexone hydrochloride release and solvent removal rate from an injectable in situ forming PLGA implant.", Polym. Adv. Technol., 17, 354-359, 2006.
8. Astaneh R., Erfan M., Moghimi H.R., Mobedi H., "Changes in morphology of in situ forming plga implant prepared by different polymer molecular weight and its effect on release behavior", J. Pharm. Sci., 98, 135-145, 2008.
9. Algin Yapar, E., Baykara, T., "Effects of variations in formulation components on drug release from injectable in situ implants", Med. J. Sci.&Techn. Res., 2(2), 2009, (in press).
10. Raman C., McHugh A.J., "A model for drug release from fast phase inverting injectable solutions", J. Control Release, 102, 145-157, 2005.
11. Algin Yapar, E., Baykara, T., "Effects of solvent combinations on drug release from injectable phase sensitive liquid implants", Turk J. Pharm. Sc., 7(1), 2010, (in press).
12. Bernkopf, M., "Sterilisation of bioresorbable polymer implants", Medical Device Technolog., 4, 26-29, 2007.
13. Bushell, J. A., Claybourn, M., Williams, H.E., Murphy, D.M., "An EPR and ENDOR study of g- and h-radiation sterilization in poly (lactide-co-glycolide) polymers and microspheres", J. Control. Releas., 110, 49-57, 2005.
14. Rafienia, M., Mirzadeh, H., Mobedi., H., Jamshidi, A., "In vitro evaluation of drug solubility and gamma irradiation on the release of betamethasone under similated in vivo conditions", J. Bioactive and Compatible Polymer., 22, 443-459, 2007.
15. Algin Yapar, E., Baykara, T., "Effect of gamma irradiation sterilization on drug release from in situ forming injectable implant systems", J. Fac. Pharm. Ankar., 37(1), 1-10, 2008.
16. Ravivarapu H.B., Moyer K.L., Dunn R.L., "Sustained activity and release of leuprolide acetate from an in situ forming polymeric implant", AAPS Pharm. Sci. Tech., 1(1), 1-8, 2000.
17. Brodbeck, K.J., Desnoyer, J.R., McHugh, A.J., "Sustained release of human growth hormone from PLGA solution depots", Pharm. Res., 16(12), 1825-1829, 1999.
18. Ravivarapu H.B., Moyer K.L., Dunn R.L., "Sustained suppression of pituitary- gonadal axis with an injectable, in situ forming implant of leuprolide acetate", J. Pharm. Sci., 89, 732-741, 2000.
19. Aapro, M., "Granisetron: an update on its clinical use in the management of nausea and vomiting", The Oncologist, 9, 673, 2004.
20. European Pharmacopoeia, 6th, Council of Europe, Strasbourg Cedex, France, 2007.
21. Pinguet, F., Bressolle, F., Martel, P., Salabert, D., Astre, C., "High-performance liquid chromatographic determination of granisetron in human plasma", J. Chromatogr., B: Biomed. Appl., 675(1), 99-105, 1996.
22. ALOGPS 2.1 Virtual Computational Chemistry Laboratory, http://www.vcclab.org/lab/alogps/, 2001.
23. Algin Yapar, E., "Development of Sustained Drug Delivery Systems as In situ Forming Injectable Implants", PhD Thesis., 2009.
24. Physicians Desk Reference 59th Ed., Thomson PDR, New Jersey, p: 2898-2903, 2005.